FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’

The FDA has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults with early symptomatic Alzheimer’s disease. Read More in FOX News.   Read More in Red Pill NOWlej.